Abstract
BackgroundMeasurements of Huntington’s disease (HD) progression, such as clinical test scores and medical imaging, can provide powerful markers for clinical applications. However, individual data can be confounded by inter-subject variability,...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
